Evidence map›Paper›PMID 27467732›Full record

ArticlePloS one2016

Ketamine Protects Gamma Oscillations by Inhibiting Hippocampal LTD.

Lanting Huang, Xiu-Juan Yang, Ying Huang, Eve Y Sun, Mu Sun

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Lanting HuangNeurodegeneration Discovery Performance Unit, GSK, R&D Shanghai, Building 1, 917 Halei Road, Zhangjiang Hi-tech Park, Pudong, Shanghai, China.
Xiu-Juan YangNeurodegeneration Discovery Performance Unit, GSK, R&D Shanghai, Building 1, 917 Halei Road, Zhangjiang Hi-tech Park, Pudong, Shanghai, China.
Ying HuangDepartment of Physiology and Pathophysiology, Shanghai Medical College, Fudan University, Shanghai, China.
Eve Y SunStem Cell Translational Research Center, Tongji Hospital, School of Medicine, Collaborative Innovation Center for Brain Science, Tongji University, Shanghai, China.
Mu SunNeurodegeneration Discovery Performance Unit, GSK, R&D Shanghai, Building 1, 917 Halei Road, Zhangjiang Hi-tech Park, Pudong, Shanghai, China.ORCID http://orcid.org/0000-0001-8261-3705
GlaxoSmithKline (China) · CNTongji University · CNShanghai Medical College of Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

NMDA receptors have been widely reported to be involved in the regulation of synaptic plasticity through effects on long-term potentiation (LTP) and long-term depression (LTD). LTP and LTD have been implicated in learning and memory processes. Besides synaptic plasticity, it is known that the phenomenon of gamma oscillations is critical in cognitive functions. Synaptic plasticity has been widely studied, however it is still not clear, to what degree synaptic plasticity regulates the oscillations of neuronal networks. Two NMDA receptor antagonists, ketamine and memantine, have been shown to regulate LTP and LTD, to promote cognitive functions, and have even been reported to bring therapeutic effects in major depression and Alzheimer's disease respectively. These compounds allow us to investigate the putative interrelationship between network oscillations and synaptic plasticity and to learn more about the mechanisms of their therapeutic effects. In the present study, we have identified that ketamine and memantine could inhibit LTD, without impairing LTP in the CA1 region of mouse hippocampus, which may underlie the mechanism of these drugs' therapeutic effects. Our results suggest that NMDA-induced LTD caused a marked loss in the gamma power, and pretreatment with 10 μM ketamine prevented the oscillatory loss via its inhibitory effect on LTD. Our study provides a new understanding of the role of NMDA receptors on hippocampal plasticity and oscillations.

Indexed as

AnimalsHippocampusKetamineLong-Term Synaptic DepressionMaleMemantineMiceMice, Inbred C57BLSynaptic PotentialsKetamineMemantine

Identifiers

PMID27467732
PMCPMC4965035
OpenAlexW2488453649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.